Notable Downgrades: Myriad Genetics (MYGN), SanDisk Corp. (SNDK), Exact Sciences (EXAS)

Analysts at Goldman (GS) downgraded Myriad Genetics Inc. (MYGN) from ‘Neutral‘ to ‘Sell‘ in a research report issued to clients on Thursday. The target price for MYGN is lowered from $31 to $25, implying 19% downside. On valuation measures, Myriad Genetics Inc. stock it’s trading at a forward P/E multiple of 18.35x, and at a […] View the full post at: Notable Downgrades: Myriad Genetics (MYGN), SanDisk Corp. (SNDK), Exact Sciences (EXAS) Related posts: Chinese Think-Tank Sees 2010 GDP Growth at 9.9% Caterpillar Inc. Downgraded to “Neutral” at BofA Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.